Like us, you might have noticed the VanEck Global Healthcare Leaders ETF (ASX: HLTH) and think that now could be a good time to consider taking a closer look. Here’s what ETF investors need to know.
1. What does the HLTH ETF do for investors?
The HLTH ETF invests in shares of international healthcare companies which offer growth ‘at a reasonable price’. Meaning, the ETF aims to invest in shares according to the common GARP methodology.
2. Funds under management (FUM)
The VanEck HLTH ETF had $37.08 million of money invested when we last pulled the monthly numbers. With a funds under management (FUM) or ‘market cap’ figure of less than $100 million, it’s important to consider if this ETF is still too small.
We say an ETF with more than $100 million invested is typically more sustainable than one with less than $100 million (at least). This is because if an ETF is too small, it may not be sustainable for an ETF issuer/provider, such as VanEck, to continue to operate it.
That said, there are exceptions to this rule of thumb, especially if the ETF issuer is committed to growing the ETF’s FUM to the point where it becomes profitable.
3. Don’t forget about the fees & costs
VanEck charges investors a yearly management fee of 0.45% for the HLTH ETF. This means that if you invested $2,000 in HLTH for a full year, you could expect to pay management fees of around $9.00.
For context, the average management fee (MER) of all ETFs covered by Best ETFs Australia on our complete list of ASX ETFs is 0.5% or around $10.00 per $2,000 invested. Keep in mind, small changes in fees can make a big difference after 10 or 20 years.
These are just a few of the considerations or factors you would need to look at when running the rule over the HLTH ETF. Before you go any further, take a look at our free VanEck HLTH report. And while you’re at it, don’t forget to search our complete list of ASX ETFs.